Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 205.01

+2.1%

11:33 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: WTDEC who wrote (22394)	6/17/1998 6:12:00 PM
From: Flagrante Delictu	Read Replies (5) of 32384

Walter, To quote from Bloomberg's report on the story, " The FDA's letter means the drug can't be approved until the deficiencies are corrected", the companies said. Still, officials of SRGN said the agency's action was not a significant setback for the drug. "We don't view this as something that is unusual or daunting or larger than usual" said Jean Nichols, president & chief technology officer at SRGN. " This is primarily clarification" of the company's studies, she said."It's not new data, not new trials."

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next